Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients

被引：1
|
作者：
Yu-Ming Chang
Shih-Ching Tsai
Chih-Chung Shiao
Hung-Hsiang Liou
Chuan-Lan Yang
Nai-Yu Tung
Kua-Sui Hsu
I-Ling Chen
Mei-Chyn Liu
Jsun-Liang Kao
Rong-Na Jhen
Ya-Ting Huang
机构：
[1] Department Saint Mary’s Hospital Luodong,Division of Nephrology, of Internal Medicine
[2] Hsin-Jen Hospital,Division of Nephrology, Department of Internal Medicine
[3] Saint Mary’s Hospital Luodong,Department of Nursing
[4] Saint Mary’s Hospital Luodong,Nutrition Room
[5] Hsin-Ren Clinics,Dialysis Center
来源：
Clinical and Experimental Nephrology | 2017年 / 21卷
关键词：
FGF23; Hemodialysis; Hepcidin; Phosphate binders;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：908 / 916
页数：8
相关论文
共 50 条
  • [41] The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
    Block, Geoffrey A.
    Rosenbaum, David P.
    Yan, Andrew
    Greasley, Peter J.
    Chertow, Glenn M.
    Wolf, Myles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (02) : 339 - 346
  • [42] Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
    Wolf, Myles
    Block, Geoffrey A.
    Chertow, Glenn M.
    Cooper, Kerry
    Fouqueray, Bruno
    Moe, Sharon M.
    Sun, Yan
    Tomlin, Holly
    Vervloet, Marc
    Oberbauer, Rainer
    CLINICAL KIDNEY JOURNAL, 2020, 13 (01) : 75 - 84
  • [43] Impact of sevelamer hydrochloride on fibroblast growth factor-23 levels in patients undergoing hemodialysis
    Ahmed, Fatma Abdelrahman
    Khalil, Amr
    Elsaid, Tamer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2548 - I2548
  • [44] Impact of sevelamer hydrochloride on fibroblast growth factor-23 levels in patients undergoing hemodialysis
    Ahmed, Fatma Abdelrahman
    Khalil, Amr
    Elsaid, Tamer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [45] Did Lanthanum Carbonate Improve Prognosis in Patients Requiring Chronic Hemodialysis in the Kawashima Study?
    Oka, Yoshinari
    Matsuda, Hiroaki
    Miyazaki, Masashi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (05) : 538 - 539
  • [46] Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial
    Ogata, Hiroaki
    Fukagawa, Masafumi
    Hirakata, Hideki
    Kagimura, Tatsuo
    Fukushima, Masanori
    Akizawa, Tadao
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (19): : 1946 - 1954
  • [47] Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study
    Jovanovich, Anna
    You, Zhiying
    Isakova, Tamara
    Nowak, Kristen
    Cheung, Alfred
    Wolf, Myles
    Chonchol, Michel
    Kendrick, Jessica
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (04) : 263 - 270
  • [48] EVALUATING ADHERENCE TO CALCIUM CARBONATE EMULSION (CCE) VERSUS CALCIUM CARBONATE TABLETS (CCT) FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS ON CHRONIC HEMODIALYSIS
    Guinsburg, Martin
    Guinsburg, Adrian
    Garrote, Norma
    Moretto, Hector
    Garcia, Leticia
    Blanco, Marina
    Ravazzio, Malvina
    Wust, Mariana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [49] Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis
    Fumiko Kojima
    Keiko Uchida
    Tetsuya Ogawa
    Yoshiko Tanaka
    Kosaku Nitta
    International Urology and Nephrology, 2008, 40 : 1067 - 1074
  • [50] Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis
    Kojima, Fumiko
    Uchida, Keiko
    Ogawa, Tetsuya
    Tanaka, Yoshiko
    Nitta, Kosaku
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1067 - 1074
12345